Information between 5th December 2021 - 11th August 2024
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
Division Votes |
---|
8 Dec 2021 - Armed Forces Bill - View Vote Context Lord O'Shaughnessy voted No - in line with the party majority and against the House One of 168 Conservative No votes vs 1 Conservative Aye votes Tally: Ayes - 215 Noes - 173 |
13 Dec 2021 - Police, Crime, Sentencing and Courts Bill - View Vote Context Lord O'Shaughnessy voted No - in line with the party majority and in line with the House One of 155 Conservative No votes vs 0 Conservative Aye votes Tally: Ayes - 83 Noes - 183 |
8 Dec 2021 - Armed Forces Bill - View Vote Context Lord O'Shaughnessy voted No - in line with the party majority and against the House One of 170 Conservative No votes vs 1 Conservative Aye votes Tally: Ayes - 205 Noes - 183 |
13 Dec 2021 - Police, Crime, Sentencing and Courts Bill - View Vote Context Lord O'Shaughnessy voted No - in line with the party majority and in line with the House One of 150 Conservative No votes vs 1 Conservative Aye votes Tally: Ayes - 171 Noes - 171 |
13 Dec 2021 - Police, Crime, Sentencing and Courts Bill - View Vote Context Lord O'Shaughnessy voted No - in line with the party majority and in line with the House One of 143 Conservative No votes vs 0 Conservative Aye votes Tally: Ayes - 71 Noes - 167 |
14 Dec 2021 - Advanced Research and Invention Agency Bill - View Vote Context Lord O'Shaughnessy voted No - in line with the party majority and against the House One of 144 Conservative No votes vs 0 Conservative Aye votes Tally: Ayes - 166 Noes - 153 |
15 Dec 2021 - Health Protection (Coronavirus, Restrictions) (Entry to Venues and Events) (England) Regulations 2021 - View Vote Context Lord O'Shaughnessy voted No - in line with the party majority and in line with the House One of 105 Conservative No votes vs 11 Conservative Aye votes Tally: Ayes - 38 Noes - 205 |
15 Dec 2021 - Police, Crime, Sentencing and Courts Bill - View Vote Context Lord O'Shaughnessy voted No - in line with the party majority and in line with the House One of 143 Conservative No votes vs 0 Conservative Aye votes Tally: Ayes - 154 Noes - 165 |
15 Dec 2021 - Police, Crime, Sentencing and Courts Bill - View Vote Context Lord O'Shaughnessy voted No - in line with the party majority and in line with the House One of 135 Conservative No votes vs 1 Conservative Aye votes Tally: Ayes - 149 Noes - 149 |
Tweets |
---|
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
28 Nov 2021, 1:40 p.m. @jonathansimons I think this is 100% right, and indeed the lineage is even longer - going back to Callaghan’s ‘secret garden’ speech in 1976. Link to Original Tweet |
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
8 May 2020, 8:08 a.m. The COVID crisis has brought out the best of Britain’s spirit. Now @ukonward is calling for a #socialstimulus to amplify that spirit so we emerge a stronger, more connected society. ? https://t.co/QQzgqVluo9 Link to Original Tweet |
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
15 May 2020, 4:31 p.m. Fantastic report on a cause very close to my heart. Sports clubs like @AFCWimbledon are often the centrepiece of community life - we need to support them during the crisis, and help them lead our recovery. https://t.co/C9gSi0kdxm Link to Original Tweet |
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
25 Jun 2020, 10:45 a.m. @danny__kruger @dianabarran Congratulations Danny - the social fabric project @ukonward is at your service Link to Original Tweet |
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
25 Jun 2020, 10:47 a.m. @virginmedia my internet in London W3 has been down for hours. Your service status webpage is broken. The helpline won’t even accept my call. Awful customer service. When will it be fixed? Link to Original Tweet |
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
25 Jun 2020, 11:14 a.m. @ruskin147 @virginmedia Not working for me in W3. But what’s really bad is service status webpage is broken, the service status info line says no outages, and the helpline is impossible to reach. Terrible service! Link to Original Tweet |
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
9 Sep 2020, 10:07 a.m. Next Monday I'll be launching @ukonward's new report - The State of our Social Fabric - with Culture Secretary @OliverDowden. Sign up to our webinar here (https://t.co/F8VHb0f17E) and join us to discuss this landmark new research on renewing Britain's communities. https://t.co/nBmblKAA9m Link to Original Tweet |
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
22 May 2020, 7:15 a.m. “We could be individualistic, anti-authority, daring and self-sufficient because on an elemental level we felt so damn safe.” Perfect summary of why the covid crisis is accelerating the shift towards security and a #politicsofbelonging https://t.co/5rgawiT1N1 Link to Original Tweet |
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
12 Apr 2020, 9:04 p.m. Within great struggles come moments of light. One of these is the idea of #COVID19 contact tracing - the key tech that will get us back to normality. This website explains how it can work https://t.co/yQAyIcn0D2 in a way that fully respects individual privacy. #NHSx Link to Original Tweet |
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
1 May 2020, 5:26 p.m. Very much this ?. And a big shout out to the officials, medical staff, logistics folks and others who helped make it happen. ?? Onwards and upwards https://t.co/l4TGdsVdWK Link to Original Tweet |
Lord O'Shaughnessy (Conservative - Life peer) - @jamesosh
2 Feb 2021, 2:46 p.m. As countries map out their COVID recovery, vaccine & immunity passports are a hot topic. The @AdaLovelaceInst has launched a call for evidence https://t.co/zzn8RnRcJz. Link to Original Tweet |
Written Answers |
---|
Clinical Trials: Contracts
Asked by: Chi Onwurah (Labour - Newcastle upon Tyne Central and West) Tuesday 30th April 2024 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, with reference to the policy paper entitled Full government response to the Lord O'Shaughnessy review into commercial clinical trials, last updated on 8 December 2023, what her Department's planned timetable is for expanding the national contract value review programme to phase 1 and 2a clinical trials. Answered by Andrew Stephenson The National Contract Value Review (NCVR) process applies to commercial clinical studies. NHS England is working in partnership with the devolved administrations, the National Institute for Health and Care Research, and other partners, to pilot the use of the NCVR process for phase I and IIa of commercial clinical trials. The ambition is to make the use of NCVR for phase I and IIa of commercial clinical trials mainstream from October 2024. |
Commercial Clinical Trials in the UK Review
Asked by: Ranil Jayawardena (Conservative - North East Hampshire) Tuesday 21st November 2023 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, what steps her Department has taken to implement the (a) significant actions under problem statement 6 and (b) other recommendations of the Lord O'Shaughnessy review of commercial clinical trials. Answered by Andrew Stephenson The Government will soon publish a full response to the Lord O’Shaughnessy independent review into commercial clinical trials. The response will include an update on progress and implementation of the initial five headline commitments and foundational actions that the Government made in May 2023 as well as all other recommendations in the review. |
IVF
Asked by: Lord Alton of Liverpool (Crossbench - Life peer) Tuesday 13th June 2023 Question to the Department of Health and Social Care: To ask His Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 6 April 2017 (HL6515), whether the Human Fertilisation and Embryology Authority has been made aware that any child born as a result of mitochondrial donation has (1) a mitochondrial disease, (2) birth defect, (3) genetic abnormality, or (4) any other adverse outcome. Answered by Lord Markham The Human Fertilisation and Embryology Authority has advised that it cannot provide the detailed information as requested as it may compromise patient confidentiality. |
Clinical Trials: Reviews
Asked by: Chi Onwurah (Labour - Newcastle upon Tyne Central and West) Tuesday 28th March 2023 Question to the Department for Science, Innovation & Technology: To ask the Secretary of State for Science, Innovation and Technology, with reference to the press release entitled Lord O'Shaughnessy to lead independent review into UK clinical trials, published on 20 February 2023, how many staff from the Department of (a) Science, Innovation and Technology, (b) Health and Social Care and (c) Business and Trade will be involved in the review. Answered by George Freeman The Office for Life Sciences is providing secretariat support for the review and is a joint unit between Department for Health and Social Care and Department for Science, Innovation and Technology. Three members of OLS staff are involved in this secretariat function as part of their roles. No members of the Department for Business and Trade are providing direct support. Officials from both DHSC and DSIT are providing evidence for the review as experts in Clinical Research. |
Clinical Trials: Reviews
Asked by: Chi Onwurah (Labour - Newcastle upon Tyne Central and West) Wednesday 1st March 2023 Question to the Department for Science, Innovation & Technology: To ask Secretary of State for Science, Innovation and Technology, with reference to the press release entitled Lord O'Shaughnessy to lead independent review into UK clinical trials, published on 20 February 2023, what the salary for leading the review is. Answered by George Freeman Lord O’Shaughnessy has been appointed as Chair for the independent review into UK clinical trials. Lord O’Shaughnessy is not a government official and the role is unpaid. |
Clinical Trials: Reviews
Asked by: Chi Onwurah (Labour - Newcastle upon Tyne Central and West) Monday 27th February 2023 Question to the Department for Science, Innovation & Technology: To ask Secretary of State for Science, Innovation and Technology, with reference to the press release entitled Lord O'Shaughnessy to lead independent review into UK clinical trials, published on 20 February 2023, what budget her Department has allocated to the review. Answered by George Freeman No specific budget has been allocated to the review. Existing staff have been temporarily re-allocated in order to support the running of the review. |
Lord O'Shaughnessy
Asked by: Angela Rayner (Labour - Ashton-under-Lyne) Monday 25th April 2022 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, what records his Department holds of correspondence between Lord O'Shaughnessy and companies providing covid-19 testing or testing supplies, between April and August 2020, conducted on his private gmail account; and whether he was provided with a departmental email address in his capacity as an adviser on NHS Test and Trace during this period. Answered by Edward Argar - Shadow Secretary of State for Justice The Department holds copies of correspondence between Lord O’Shaughnessy’s Gmail account and Government officials, companies and organisations working on COVID-19 testing and testing supplies issues between April and August 2020. During this period Lord O’Shaughnessy was provided with a Departmental email address. |
Centre for Improving Data Collaboration
Asked by: Angela Rayner (Labour - Ashton-under-Lyne) Tuesday 22nd March 2022 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, whether his Department holds a minute of the meeting between the Parliamentary Under Secretary for Innovation, Lord O'Shaughnessy and Imperial College London regarding the Centre for Improving Data Collaboration; whether Departmental officials were present; and in what capacity Lord O'Shaugnessy attended that meeting. Answered by Gillian Keegan Lord O’Shaughnessy and colleagues at the Imperial Institute for Global Health Innovation undertook a piece of research on behalf of the NHSX Centre for Improving Data Collaboration, to contribute to the development of the Value Sharing Framework for health data partnerships. Departmental officials were present and the Department holds a minute of the meeting.
|
OC&C Strategy Consultants
Asked by: Rachel Hopkins (Labour - Luton South and South Bedfordshire) Tuesday 22nd March 2022 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, whether his Department holds a minute of the meetings between the Parliamentary Under Secretary of State for Innovation, Lord O'Shaughnessy and OC&C strategy consultants on 13 April 2020; who attended the meeting on behalf of OC&C; whether officials or special advisers attended the meeting on behalf of his Department; and in what capacity Lord O'Shaughnessy was attending. Answered by Edward Argar - Shadow Secretary of State for Justice The Department holds notes of the actions arising from this meeting. Lord Bethell was supported by a private secretary, Departmental officials and officials from the Department for International Trade, Department for Environment, Food and Rural Affairs and NHS England. Lord O'Shaughnessy and Bennet Summers, Vivek Madan and Henry Stannard of OC&C Strategy also attended the meeting. Special advisors were not present. Lord O'Shaughnessy attended in an advisory capacity. |
Parliamentary Research |
---|
Musculoskeletal conditions and employment - CDP-2023-0236
Dec. 20 2023 Found: Answering member: Lord O'Shaughnessy | Department: Department of Health and Social Care The Government |
Eye health and macular disease - CDP-2021-0220
Dec. 23 2021 Found: Answering member: Lord O'Shaughnessy | Department of Health Bevacizumab (Avastin) is not licensed |
Department Publications - Policy and Engagement |
---|
Friday 1st March 2024
Department of Health and Social Care Source Page: The antimicrobial potential of bacteriophages report: government response Document: Government's response to the Science, Innovation and Technology Committee's report 'The antimicrobial potential of bacteriophages' (PDF) Found: The Lord O'Shaughnessy review into commercial clinical trials in the UK ( 8) was commissioned by the |
Wednesday 22nd November 2023
Department of Health and Social Care Source Page: Government response to the review into commercial clinical trials Document: Government response to the review into commercial clinical trials (webpage) Found: Government response to the review into commercial clinical trials The full government response to the Lord |
Deposited Papers |
---|
Tuesday 28th November 2023
Department of Health and Social Care Source Page: Policy paper. Full government response to the Lord O'Shaughnessy review into commercial clinical trials. 40p. Document: Full_response-OShaughnessy_Review.pdf (PDF) Found: Full government response to the Lord O'Shaughnessy review into commercial clinical trials. 40p. |
Scottish Cross Party Group Publications |
---|
Minutes of the meeting held on 30 May 2023
(PDF) Source Page: Cross-Party Group in the Scottish Parliament on Life Sciences Published: 30th May 2023 Found: Asked for her views on the recently published Lord O'Shaughnessy report which makes a series of re |